Baxter International (BAX) Gets a Hold from Bank of America Securities
Bank of America Securities analyst Travis Steed reiterated a Hold rating on Baxter International today and set a price target of $24.00.
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
Steed covers the Healthcare sector, focusing on stocks such as Boston Scientific, Intuitive Surgical, and Stryker. According to TipRanks, Steed has an average return of 0.8% and a 49.27% success rate on recommended stocks.
In a report released on May 29, Citi also downgraded the stock to a Hold with a $17.00 price target.
Based on Baxter International’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.7 billion and a GAAP net loss of $15 million. In comparison, last year the company earned a revenue of $2.63 billion and had a net profit of $126 million
Read More on BAX:
Disclaimer & DisclosureReport an Issue
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Midday Fly By: Snowflake reports Q1 beat, Salesforce posts beat and raise
- Dick’s Sporting upgraded, Trade Desk initiated: Wall Street’s top analyst calls
- Baxter downgraded to Sell from Neutral at Citi
- Baxter Updates Executive Severance Plan and Governance Framework
